Intradermal Hepatitis-B-vaccination in non-responders after topical application of imiquimod 5%.

Trial Profile

Intradermal Hepatitis-B-vaccination in non-responders after topical application of imiquimod 5%.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 04 Jun 2010

At a glance

  • Drugs Imiquimod (Primary) ; Hepatitis B vaccine recombinant (HBvaxPro)
  • Indications Hepatitis B
  • Focus Pharmacodynamics
  • Most Recent Events

    • 04 Jun 2010 Results published in Vaccine.
    • 04 Jun 2010 Status changed from recruiting to active, no longer recruiting.
    • 23 Sep 2009 Last checked against Netherlands Trial Register
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top